![Hsing I Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hsing I Chen began roles at Elixiron Immunotherapeutics (Cayman) Ltd. and PharmaEssentia Corp.
in 2025.
At Elixiron Immunotherapeutics (Cayman) Ltd., the role is Independent Director starting in 2025.
At PharmaEssentia Corp., the role is Chief Legal Officer starting in 2025.
Both roles are current.
| Companies | Position | Start |
|---|---|---|
| ELIXIRON IMMUNOTHERAPEUTICS (CAYMAN) LIMITED | Director/Board Member | 23/10/2025 |
| PHARMAESSENTIA CORPORATION | General Counsel | 09/05/2025 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
PharmaEssentia Corp.
 PharmaEssentia Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells therapeutic products for the treatment of hematologic diseases | Health Technology |
Elixiron Immunotherapeutics, Inc.
 Elixiron Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision immunotherapy drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
